NCT06743126 2026-04-13
SUPRAME
Immatics US, Inc.
Phase 3 Recruiting
Clinical Trials
5 trialsNCT05479812 2026-02-09
Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors
Werewolf Therapeutics, Inc.
Phase 1 Active not recruiting
NCT05585320 2025-09-02
A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors
Immuneering Corporation
Phase 1/2 Active not recruiting
NCT06208124 2025-05-28
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors
Immuneering Corporation
Phase 1/2 Completed
NCT03541148 2018-05-30
Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma
Catalysis SL
Phase 2 Completed